In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big chunk of the ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Ozempic is the version of Novo Nordisk's semaglutide ... GLP-1 agonists have evolved into powerful tools for weight management and broader cardiometabolic health. Yet, as their use skyrockets ...

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).